المؤلفون: García Martínez, Rafael, Sanz Gea, Clara, Martin Riera, Victor, Guerra-Ruiz, Armando, Paciucci Barzanti, Rosanna, Ferrer Costa, Roser, Ramírez Serra, Clara

المساهمون: Institut Català de la Salut, [Martínez RJG] Clinical Analysis Department, Marqués de Valdecilla University Hospital, Santander, Spain. Evidence-Based Laboratory Medicine Commission, Spanish Society of Laboratory Medicine (SEQCML), Barcelona, Spain. [Gea CS, Martin-Riera V, Ruiz ARG, Barzanti RP, Ferrer-Costa R, Ramirez-Serra C] Grup de Recerca de Bioquímica Clínica, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei de Bioquímica Clínica, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: acciones y usos químicos::acciones farmacológicas::mecanismos moleculares de acción farmacológica::inhibidores enzimáticos::inhibidores de proteínas cinasas [COMPUESTOS QUÍMICOS Y DROGAS], enfermedades respiratorias::enfermedades pleurales::quilotórax [ENFERMEDADES], Other subheadings::Other subheadings::/chemically induced [Other subheadings], Other subheadings::Other subheadings::/adverse effects [Other subheadings], Otros calificadores::Otros calificadores::/inducido químicamente [Otros calificadores], Proteïnes quinases - Inhibidors - Efectes secundaris, Respiratory Tract Diseases::Pleural Diseases::Chylothorax [DISEASES], Otros calificadores::Otros calificadores::/efectos adversos [Otros calificadores], Embassament pleural, Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Enzyme Inhibitors::Protein Kinase Inhibitors [CHEMICALS AND DRUGS]

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=od______3991::6195967669a2e1a957b9e627177d10e5Test
https://hdl.handle.net/11351/9488Test

المؤلفون: Sheila, Bermejo, Mónica, Bolufer, Mar, Riveiro-Barciela, Maria José, Soler

المساهمون: Institut Català de la Salut, [Bermejo S, Bolufer M, Soler MJ] Servei de Nefrologia, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Centro de Referencia en Enfermedad Glomerular Compleja del Sistema Nacional de Salud (CSUR), Barcelona, Spain. [Riveiro-Barciela M] Unitat Hepàtica, Servei de Medicina Interna, Vall d'Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Nefrotoxicologia, Other subheadings::Other subheadings::/chemically induced [Other subheadings], Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents::Antineoplastic Agents, Immunological [CHEMICALS AND DRUGS], Immunotoxicologia, Other subheadings::Other subheadings::/adverse effects [Other subheadings], enfermedades urogenitales masculinas::enfermedades urológicas::enfermedades renales::nefritis::nefritis intersticial [ENFERMEDADES], Otros calificadores::Otros calificadores::/inducido químicamente [Otros calificadores], Medicaments - Toxicologia, Male Urogenital Diseases::Urologic Diseases::Kidney Diseases::Nephritis::Nephritis, Interstitial [DISEASES], General Medicine, Otros calificadores::Otros calificadores::/efectos adversos [Otros calificadores], acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antineoplásicos::inmunoterapia antineoplásica [COMPUESTOS QUÍMICOS Y DROGAS]

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a04a06d6c4d004da794a5387cef599bTest
https://hdl.handle.net/11351/8175Test

المؤلفون: Elgene Lim, Frances Boyle, Meena Okera, Sherene Loi, Sema Sezgin Goksu, Gertjan van Hal, Sonya C. Chapman, Jonathon Colby Gable, Yanyun Chen, Gregory L. Price, Anwar M. Hossain, M. Corona Gainford, Meritxell Bellet Ezquerra

المساهمون: Institut Català de la Salut, [Lim E] Garvan Institute of Medical Research, St. Vincent’s Clinical School, University of New South Wales, Darlinghurst, NSW, Australia. [Boyle F] Mater Hospital, North Sydney, NSW, Australia. [Okera M] Adelaide Cancer Centre, Kurralta Park, SA, Australia. [Loi S] Peter MacCallum Cancer Centre, Melbourne, VI, Australia. [Sezgin Goksu S] Akdeniz University Medical Faculty, Antalya, Turkey. [van Hal G] Eli Lilly and Company, Utrecht, Netherlands. [Bellet Ezquerra M] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Diarrhea, Cancer Research, neoplasias::neoplasias por localización::neoplasias de la mama [ENFERMEDADES], Pathological Conditions, Signs and Symptoms::Signs and Symptoms::Signs and Symptoms, Digestive::Diarrhea [DISEASES], afecciones patológicas, signos y síntomas::signos y síntomas::signos y síntomas digestivos::diarrea [ENFERMEDADES], Neoplasms::Neoplasms by Site::Breast Neoplasms [DISEASES], Otros calificadores::Otros calificadores::/inducido químicamente [Otros calificadores], Aminopyridines, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Breast Neoplasms, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Loperamide, Medicaments antineoplàstics - Efectes secundaris, Oncology, Antineoplastic Combined Chemotherapy Protocols, Mama - Càncer - Tractament, Other subheadings::Other subheadings::/chemically induced [Other subheadings], Humans, Benzimidazoles, Female, Diarrea

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09833212ade89e0baa9018b90ea57d61Test
https://doi.org/10.21203/rs.3.rs-1440521/v1Test

المؤلفون: Mallah, Narmeen, Zapata-Cachafeiro, Maruxa, Aguirre, Carmelo, Ibarra-García, Eguzkiñe, Palacios-Zabalza, Itziar, Macías-García, Fernando, Piñeiro-Lamas, María, Ibáñez, Luisa, Vidal Guitart, Xavier, Vendrell Bosch, Lourdes, Martin-Arias, Luis, Sáinz-Gil, María, Velasco-González, Verónica, Bacariza-Cortiñas, Manuel, Salgado, Angel, Estany-Gestal, Ana, Figueiras, Adolfo, Universitat Autònoma de Barcelona

المساهمون: Institut Català de la Salut, [Mallah N] Department of Preventive Medicine, University of Santiago de Compostela, Santiago de Compostela, Spain. WHO Collaborating Centre for Vaccine Safety, Santiago de Compostela, Spain. Genetics, Vaccines and Pediatric Infectious Diseases Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago de Compostela, Santiago de Compostela, Spain. Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBER-ES), Carlos III Health Institute, Madrid, Spain. [Zapata-Cachafeiro M] Department of Preventive Medicine, University of Santiago de Compostela, Santiago de Compostela, Spain. Consortium for Biomedical Research in Epidemiology and Public Health (CIBER en Epidemiología y Salud Pública-CIBERESP), Carlos III Health Institute, Madrid, Spain. [Aguirre C] Pharmacotherapy Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain. Basque Country Pharmacovigilance Unit, University Hospital of Galdakao-Usansolo, Osakidetza, Spain. Pharmacology Department, Medicine and Nursing Faculty, University of the Basque Country, Barakaldo, Spain. [Ibarra-García E] Department of Preventive Medicine, University of Santiago de Compostela, Santiago de Compostela, Spain. Pharmacotherapy Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain. Osakidetza Basque Health Service, Pharmacy Department, Urduliz Hospital, Urduliz, Spain. [Palacios-Zabalza I] Pharmacotherapy Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain. Basque Country Pharmacovigilance Unit, University Hospital of Galdakao-Usansolo, Osakidetza, Spain. [Macías-García F] Department of Gastroenterology and Hepatology, University Hospital of Santiago de Compostela, Santiago de Compostela, Spain. [Ibáñez L, Vidal X, Vendrell L] Catalonian Institute of Pharmacology, Barcelona, Spain. Servei de Farmacologia Clínica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Departament de Farmacologia, de Terapèutica i de Toxicologia, Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Addi. Archivo Digital para la Docencia y la Investigación
instname
Annals of Medicine
article-version (VoR) Version of Record
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Annals of Medicine, Vol 54, Iss 1, Pp 379-392 (2022)
Scientia

مصطلحات موضوعية: aspirin, Otros calificadores::Otros calificadores::/inducido químicamente [Otros calificadores], interaction, Otros calificadores::Otros calificadores::/efectos adversos [Otros calificadores], Polymorphism, Single Nucleotide, Risk Factors, Other subheadings::Other subheadings::/adverse effects [Other subheadings], afecciones patológicas, signos y síntomas::procesos patológicos::hemorragia::hemorragia gastrointestinal [ENFERMEDADES], Humans, non-steroidal anti-inflammatory drugs, Pathological Conditions, Signs and Symptoms::Pathologic Processes::Hemorrhage::Gastrointestinal Hemorrhage [DISEASES], Chemical Actions and Uses::Pharmacologic Actions::Physiological Effects of Drugs::Peripheral Nervous System Agents::Sensory System Agents::Analgesics::Analgesics, Non-Narcotic::Anti-Inflammatory Agents, Non-Steroidal [CHEMICALS AND DRUGS], Antiinflamatoris no esteroïdals - Efectes secundaris, Aspirin, Gastroenterology & Hepatology, upper gastrointestinal haemorrhage, Anti-Inflammatory Agents, Non-Steroidal, acciones y usos químicos::acciones farmacológicas::efectos fisiológicos de los fármacos::fármacos del sistema nervioso periférico::fármacos del sistema sensitivo::analgésicos::analgésicos no narcóticos::antiinflamatorios no esteroideos [COMPUESTOS QUÍMICOS Y DROGAS], General Medicine, Hemorràgia gastrointestinal, Case-Control Studies, Other subheadings::Other subheadings::/chemically induced [Other subheadings], genetic variation, Medicine, Gastrointestinal Hemorrhage, Research Article

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::067bff5d932e7b6c645516ca5344db69Test
http://hdl.handle.net/10810/56735Test

المؤلفون: Bar-Or, Amit, Wiendl, Heinz, Montalban, Xavier, Alvarez, Enrique, Davydovskaya, Maria, Delgado, Silvia R., Evdoshenko, Evgeniy P., Giedraitiene, Natasa, Gross-Paju, Katrin, Haldre, Sulev, Herrman, Craig E., Izquierdo, Guillermo, Karelis, Guntis, Leutmezer, Fritz, Mares, Miroslav, Meca-Lallana, Jose Eustasio, Mickeviciene, Dalia, Nicholas, Jacqueline, Robertson, Derrick S., Sazonov, Denis V., Sharlin, Kenneth, Sundaram, Bharathy, Totolyan, Natalia, Vachova, Marta, Valis, Martin, Bagger, Morten, Häring, Dieter A., Ludwig, Inga, Willi, Roman, Zalesak, Martin, Su, Wendy, Merschhemke, Martin, Fox, Edward J., Universitat Autònoma de Barcelona

المساهمون: Institut Català de la Salut, [Bar-Or A] Center for Neuroinflammation and Experimental Therapeutics and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. [Wiendl H] Department of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany. [Montalban X] Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Alvarez E] Department of Neurology, Rocky Mountain MS Center, University of Colorado, Aurora, CO, USA. [Davydovskaya M] Pirogov Russian National Research Medical University, Moscow, Russian Federation. [Delgado SR] MS Center and Department of Neurology, Miller School of Medicine, University of Miami, Miami, FL, USA, Vall d'Hebron Barcelona Hospital Campus

المصدر: Multiple sclerosis, London : Sage Publications Ltd., 2022, vol. 28, no. 6, p. 910-924
Scientia

مصطلحات موضوعية: Multiple Sclerosis, medicine.drug_class, Injections, Subcutaneous, Otros calificadores::Otros calificadores::/inducido químicamente [Otros calificadores], Phases of clinical research, Esclerosi múltiple, Pharmacology, Bioequivalence, Ofatumumab, Monoclonal antibody, Antibodies, Monoclonal, Humanized, Multiple sclerosis, chemistry.chemical_compound, Pharmacokinetics, autoinjector pen, bioequivalence, multiple sclerosis, pharmacokinetics, pre-filled syringe, medicine, Humans, business.industry, Nervous System Diseases::Autoimmune Diseases of the Nervous System::Demyelinating Autoimmune Diseases, CNS::Multiple Sclerosis [DISEASES], Antibodies, Monoclonal, Injeccions hipodèrmiques, medicine.disease, Autoinjector pen, B cell depletion, Neurology, chemistry, Pre-filled syringe, Other subheadings::Other subheadings::/chemically induced [Other subheadings], enfermedades del sistema nervioso::enfermedades autoinmunitarias del sistema nervioso::enfermedades autoinmunes desmielinizantes del SNC::esclerosis múltiple [ENFERMEDADES], Neurology (clinical), business, Anticossos monoclonals

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fea82473f15eae98cbca7008483f7bddTest
https://pubmed.ncbi.nlm.nih.gov/34605319Test

المؤلفون: Marta Consegal, Laura Valls-Lacalle, Antonio Rodríguez-Sinovas

المساهمون: Institut Català de la Salut, [Consegal M, Rodríguez-Sinovas A] Grup de Recerca en Malalties Cardiovasculars, Servei de Cardiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Valls-Lacalle L] Biomaterials for Regenerative Therapies Group, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology, 08028 Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Revista Portuguesa de Cardiologia, Vol 40, Iss 3, Pp 201-203 (2021)
Scientia
Revista Portuguesa de Cardiologia (English Edition), Vol 40, Iss 3, Pp 201-203 (2021)

مصطلحات موضوعية: medicine.medical_specialty, lcsh:Diseases of the circulatory (Cardiovascular) system, Otros calificadores::Otros calificadores::/inducido químicamente [Otros calificadores], hormonas, sustitutos de hormonas y antagonistas de hormonas::hormonas::hormonas peptídicas::angiotensinas::angiotensina II [COMPUESTOS QUÍMICOS Y DROGAS], Cardiomyocyte hypertrophy, Cardiomegaly, Receptor, Angiotensin, Type 1, Internal medicine, Medicine, Humans, Myocytes, Cardiac, General Environmental Science, business.industry, Cardiovascular Diseases::Heart Diseases::Cardiomegaly [DISEASES], Angiotensin II, Endocrinology, Other subheadings::/pharmacology [Other subheadings], lcsh:RC666-701, Otros calificadores::/farmacología [Otros calificadores], Other subheadings::Other subheadings::/chemically induced [Other subheadings], General Earth and Planetary Sciences, Hormones, Hormone Substitutes, and Hormone Antagonists::Hormones::Peptide Hormones::Angiotensins::Angiotensin II [CHEMICALS AND DRUGS], Cardiology and Cardiovascular Medicine, business, enfermedades cardiovasculares::enfermedades cardíacas::cardiomegalia [ENFERMEDADES]

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f99e6e8e68dc1af6ae1ed3a48776648Test
https://pubmed.ncbi.nlm.nih.gov/33478847Test

المؤلفون: José María Balibrea, Roman Serrat, Carmen Berasain, Monica Higuera, Aleix Gavaldà-Navarro, Eduardo Soriano, Matías A. Avila, Iker Uriarte, María Teresa Salcedo, Francesc Villarroya, Eva Santamaría, Beatriz Minguez, Yasmina Manso, Serena Mirra, Ferran Burgaya

المساهمون: Institut Català de la Salut, [Mirra S, Manso Y, Serrat R] Department of Cell Biology, Physiology and Immunology, University of Barcelona, 08007 Barcelona, Spain. Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, 28029 Madrid, Spain. [Gavaldà-Navarro A] Department of Biochemistry and Molecular Biomedicine and Institute of Biomedicine, University of Barcelona, 08028 Barcelona, Spain. Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain. [Higuera M] Grup de Recerca en Malalties Hepàtiques, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Salcedo MT] Servei de Patologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Balibrea JM] Unitat de Cirurgia Endocrina, Metabòlica i Bariàtrica, Servei de Cirurgia General, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Mínguez B] Grup de Recerca en Malalties Hepàtiques, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III, 28029 Madrid, Spain. Unitat del Fetge, Servei de Medicina Interna, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Cancers
Scientia
Volume 13
Issue 5
Cancers, Vol 13, Iss 1110, p 1110 (2021)

مصطلحات موضوعية: 0301 basic medicine, Cancer Research, obesity, neoplasias::neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias hepáticas::carcinoma hepatocelular [ENFERMEDADES], Otros calificadores::Otros calificadores::/inducido químicamente [Otros calificadores], SOX9, Biology, medicine.disease_cause, lcsh:RC254-282, Article, Fetge - Càncer - Tractament, 03 medical and health sciences, 0302 clinical medicine, Downregulation and upregulation, NAFLD, medicine, Obesity, HCC, Gene knockdown, lipotoxicity, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, 030104 developmental biology, Neoplasms::Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Liver Neoplasms::Carcinoma, Hepatocellular [DISEASES], Oncology, Lipotoxicity, Cell culture, 030220 oncology & carcinogenesis, Hepatocellular carcinoma, Other subheadings::Other subheadings::/chemically induced [Other subheadings], Hepatic stellate cell, Cancer research, Alex3, Carcinogenesis

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59b0494b5535ce05925fea4f831fd988Test
https://ddd.uab.cat/record/255426Test